Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine.

× No keyword cloud information.

24 in total

Review 1. Do calcium antagonists have a place in the treatment of mood disorders?

Authors: C Höschl
Journal: Drugs Date: 1991-11 Impact factor: 9.546

2. Neurology: neurologic use of calcium channel blocking agents.

Authors: J F Rothrock
Journal: West J Med Date: 1987-03

Review 3. Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

Authors: K J Tietze; M L Schwartz; P H Vlasses
Journal: Drugs Date: 1987-06 Impact factor: 9.546

4. Retinal artery occlusion in migraine.

Authors: J A Gray; J D Carroll
Journal: Postgrad Med J Date: 1985-06 Impact factor: 2.401

5. Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.

Authors: I Jansen; P Tfelt-Hansen; L Edvinsson
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

Review 6. The mechanism of action of calcium antagonists relative to their clinical applications.

Authors: B N Singh
Journal: Br J Clin Pharmacol Date: 1986 Impact factor: 4.335

7. [Effect of the Ca antagonist nimodipine on global and regional cerebrovascular circulation].

Authors: M R Gaab; C P Rode; E H Schakel; I Haubitz; J Bockhorn; A Brawanski
Journal: Klin Wochenschr Date: 1985-01-02

Review 8. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors: M S Langley; E M Sorkin
Journal: Drugs Date: 1989-05 Impact factor: 9.546

9. Preventive pharmacologic treatments for episodic migraine in adults.

Authors: Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal: J Gen Intern Med Date: 2013-04-17 Impact factor: 5.128

10. Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors: Michel Dib
Journal: Ther Clin Risk Manag Date: 2008-10 Impact factor: 2.423